Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
International Congress of Parkinson’s Disease and Movement Disorders
jan 2020 | Bewegingsstoornissen